Search
Search Results
##search.searchResults.foundPlural##
-
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
1956PDF: 778HTML: 196 -
SOLITARY PLASMACYTOMA
3763PDF: 2128HTML: 1201fIGURES 1,2: 191 -
TYROSINE KINASE INHIBITORS AND PREGNANCY
3430PDF: 1579HTML: 2662 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3155PDF: 905HTML: 2928 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1534PDF: 775HTML: 139 -
CANDIDEMIA IN PATIENTS WITH ACUTE LEUKEMIA: ANALYSIS OF SEVEN YEARS’ EXPERIENCE AT A SINGLE CENTER IN CHINA Candidemia in acute Leukemia
1636PDF: 908HTML: 210 -
DISSEMINATED HISTOPLASMOSIS AS AIDS PRESENTATION. CASE REPORT AND COMPREHENSIVE REVIEW OF CURRENT LITERATURE
3562PDF: 1254HTML: 702Figure 2: 423Figure 1: 3090 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
1778PDF: 691HTML: 2084Untitled: 192Untitled: 139Untitled: 152Untitled: 141Untitled: 145Untitled: 161Untitled: 168 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4341PDF: 1872HTML: 17710 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
1879PDF: 773HTML: 206 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
892PDF: 559HTML: 2180Cover Letter: 175 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
2095PDF: 853HTML: 302 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2378HTML: 252PDF: 827 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3247PDF: 1208HTML: 2177 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2214PDF: 1298HTML: 17060Bassan Fig.1: 133Bassan Fig.2: 131Bassan Fig.4: 126Fig.3: 164 -
FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT
4323PDF: 1581HTML: 3412Tables and Images: 197 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2328PDF: 825HTML: 2440 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1729PDF: 781HTML: 10209Figures 1,2,3: 152 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4001PDF: 1534HTML: 841 -
The EVOLVING ROLE OF HAEMATOLOGY NURSING PRACTICE: A CROSS-SECTIONAL SURVEY
1665Suppl. Files: 831HTML: 403PDF: 707 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2740PDF: 980HTML: 5498 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1452PDF: 1142HTML: 171 -
HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION
3059PDF: 1086HTML: 1719 -
-
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3211PDF: 1310HTML: 2610 -
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1547PDF: 1040HTML: 100 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1160PDF: 935HTML: 192 -
THE CHALLENGE OF AML IN OLDER PATIENTS
2125PDF: 917HTML: 2146 -
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE
3524PDF: 1080HTML: 23316







